Prescribing information and Adverse event reporting can be found at the bottom of the page

This website is intended for Great Britain healthcare professionals only

Episode 2 – Optimising patient identification and referral

Hear from the perspective of both a leading oncologist and nuclear medicine consultant how they optimise the treatment and referral pathway for their patients.



  • Dr Julia Murray - Consultant Clinical Oncologist
  • Dr Amy Eccles - Consultant Radionuclide Radiologist and Clinical Lead


Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

This promotional podcast series has been initiated and funded by Bayer and is for healthcare professionals only.

XOFIGO(radium-223 dichloride) Prescribing Information can be found here.

Reflective Learning Guide

Download Reflective Learning Guide


Dr Julia Murray

Dr Julia Murray


Consultant clinical oncologist at The Royal Marsden NHS Foundation Trust and an honorary clinical senior lecturer at The Institute of Cancer Research, London, specialising in radiotherapy and systemic therapy for prostate cancer.


Dr Murray graduated from Imperial College London in 2004 and undertook her general medical training in London. Her specialist clinical oncology training was completed at The Royal Marsden, Guy’s and St Thomas’ Hospital and St Luke’s Cancer Centre. In 2013, Dr Murray was awarded a Cancer Research UK PhD Fellowship at The Institute of Cancer Research and The Royal Marsden, evaluating image-guided prostate radiotherapy and the relationship between radiation dose and toxicity. She received her PhD in 2017 and was appointed as a consultant clinical oncologist in the urology unit at The Royal Marsden later that year. She is actively involved in clinical research of advanced radiotherapy technology to improve treatment accuracy and patient outcomes. She is also a trustee of the British Uro-oncology Group.

Dr Amy Eccles

Dr Amy Eccles


Consultant Radionuclide Radiologist and Clinical Lead for Nuclear Medicine at Imperial College Healthcare NHS Trust, London.


Dr Eccles has a specialist interest in nuclear medicine imaging and therapy, including hybrid and neuro-endocrine imaging (SPECT/PET-CT) for both oncology and musculoskeletal conditions.

The Practicalities of treatment

Episode 3 - The Practicalities of treatment

Why treat with Xofigo?

Episode 1 - Why treat with Xofigo?

Want to stay in touch?

If you would like us to keep you up to date with details of future webinars and other important news updates, please stay connected using the button below.


Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at or search MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Bayer plc Tel: 01182 063 500, Fax: 01182 063 703, Email:


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.